When: CLOSED

Where: Be Well Clinical Studies

Location: Lincoln, NE

DID YOU KNOW?

• RSV is the #1 cause of hospitalization during baby’s first year

Source: Centers for Disease Control and Prevention

What is Maternal RSV?

Respiratory (“res-per-uh-taw-ree”) syncytial (“sin-sish-uhl”) virus, also called RSV, is a contagious cold-like virus that infects the airways and lungs.

• All children are at risk of RSV infection; however, severe infection is more likely in very young babies, especially younger than 6 months, than in older children.

• RSV infection is one of the most common reasons for hospitalization among very young babies.

Consider Joining this Clinical Study

The goal of the study is to learn more about a vaccine’s ability to boost the level of RSV-fighting antibodies in pregnant women and if those antibodies pass to their babies. What we learn in this study may possibly help us develop an RSV maternal vaccine in the future. 

Eligibility: 

• Health women aged 18 to 49 years

• In your second or third trimester of pregnancy (between 24 and 34 weeks of gestation)

*Additional eligibility criteria apply. Speak with the study team to learn more.

Click Volunteer to sign up.